Sirtuin 5-mediated post-translational modifications as a promising therapeutic approach to attenuate liver diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Hepatology

Background:

• Liver diseases, including acute liver injury, chronic hepatitis, liver fibrosis, and hepatoma, represent a significant global health burden.
• There is a critical need for novel therapeutic strategies to combat the progression of liver pathologies.
• Sirtuin 5 (SIRT5), an NAD+-dependent deacylase, regulates key cellular processes through desuccinylation, demalonylation, and deglutarylation.

Purpose of the Study:

• To review the current understanding of Sirtuin 5's role in the pathogenesis of liver diseases.
• To elucidate the molecular mechanisms by which SIRT5 influences liver disease progression.
• To highlight SIRT5 as a potential therapeutic target for liver disease treatment.

Main Methods:

• Literature review of studies investigating SIRT5 function in liver disease models.
• Analysis of post-translational modifications regulated by SIRT5.
• Examination of SIRT5's involvement in cellular processes like metabolism, oxidative stress, inflammation, and autophagy.

Main Results:

• Dysregulation of SIRT5 is linked to liver disease progression via metabolic imbalance, mitochondrial oxidative stress, inflammation, and altered autophagy.
• SIRT5's enzymatic activities are crucial for maintaining cellular homeostasis and preventing liver damage.
• Evidence suggests SIRT5's involvement in the pathogenesis of liver fibrosis and other liver conditions.

Conclusions:

• SIRT5 is implicated in the development and progression of various liver diseases.
• Targeting SIRT5 presents a promising therapeutic avenue for managing liver diseases.
• Further research into SIRT5's precise mechanisms is warranted to develop effective treatments.